cd23
Frederic Preffer (preffer@HELIX.MGH.HARVARD.EDU)
Fri, 05 Jan 1996 14:14:01 -0500 (EST)
At 09:27 PM 1/2/96 -0500, you wrote:
>Does anyone out in Flowspace have any experience with using CD23 for
>lymphoma/leukemia analysis?
>I would appreciate any information.
>Thanks in advance.
>Mike Mazharov
CD23 is present on all normal circulating B cells. It is useful in
distinguishing chronic lymphocytic leukemias from centrocytic/mantle zone
malignancies (both of which are all CD19+20+5+ light chain monoclonal) in
that the CLLs are generally CD23+, the centrocytics are generally CD23-.
>
`````````````````````````````````````````````````
Frederic I. Preffer
preffer@helix.mgh.harvard.edu
Department of Pathology- Cox5
100 Blossom St
Massachusetts General Hospital
Boston MA 02114
(617) 726-7481 {fax x2365}
~~~~~~~~~~~~~~~~~~~~~~~~~~~
CD ROM Vol 2 was produced by staff at the Purdue University Cytometry Laboratories
and distributed free of charge as an educational service to the cytometry community.
If you have any comments please direct them to Dr. J. Paul Robinson, Professor & Director, PUCL,
Purdue University, West Lafayette, IN 47907. Phone:(317) 494-0757; FAX (317) 494-0517; Web http://www.cyto.purdue.edu
EMAIL robinson@flowcyt.cyto.purdue.edu
